FDA Clearance Tracker · P230040
Cordella Pulmonary Artery Sensor System (CorPASS)
Last checked: Nov 19, 2026Latest source record: Jun 20, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 20, 2024
Approved
Time to decision
190 days
Received Dec 13, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230040
- Device name
- Cordella Pulmonary Artery Sensor System (CorPASS)
- Applicant
- Endotronix, Inc.
- Applicant location
- Naperville, IL
- Received
- Dec 13, 2023
- Decided
- Jun 20, 2024
- Decision
- Approved
- Supplements
- 35 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
The Cordella Pulmonary Artery Sensor System is intended to measure, record and transmit pulmonary artery pressure (PAP) data from NYHA Class III heart failure patients who are at home on diuretics and guideline-directed medical therapy (GDMT) as well as have been stable for 30 days on GDMT. The device output is meant to aid clinicians in the assessment and management of heart failure, with the goal of reducing heart failure hospitalizations.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MOM. The earliest in FDA's data is P100045, decided May 28, 2014.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Endotronix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.